BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 16428493)

  • 1. Increased NBS1 expression is a marker of aggressive head and neck cancer and overexpression of NBS1 contributes to transformation.
    Yang MH; Chiang WC; Chou TY; Chang SY; Chen PM; Teng SC; Wu KJ
    Clin Cancer Res; 2006 Jan; 12(2):507-15. PubMed ID: 16428493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of increased NBS1 expression as a prognostic marker of squamous cell carcinoma of the oral cavity.
    Hsu DS; Chang SY; Liu CJ; Tzeng CH; Wu KJ; Kao JY; Yang MH
    Cancer Sci; 2010 Apr; 101(4):1029-37. PubMed ID: 20175780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of PIK3CA and Akt/protein kinase B in head and neck squamous cell carcinoma.
    Fenic I; Steger K; Gruber C; Arens C; Woenckhaus J
    Oncol Rep; 2007 Jul; 18(1):253-9. PubMed ID: 17549376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of CXCR4 and its down-regulation by IFN-gamma in head and neck squamous cell carcinoma.
    Katayama A; Ogino T; Bandoh N; Nonaka S; Harabuchi Y
    Clin Cancer Res; 2005 Apr; 11(8):2937-46. PubMed ID: 15837745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and clinical significance of the Kv3.4 potassium channel subunit in the development and progression of head and neck squamous cell carcinomas.
    Menéndez ST; Rodrigo JP; Allonca E; García-Carracedo D; Alvarez-Alija G; Casado-Zapico S; Fresno MF; Rodríguez C; Suárez C; García-Pedrero JM
    J Pathol; 2010 Aug; 221(4):402-10. PubMed ID: 20593490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of NBS1 induces epithelial-mesenchymal transition and co-expression of NBS1 and Snail predicts metastasis of head and neck cancer.
    Yang MH; Chang SY; Chiou SH; Liu CJ; Chi CW; Chen PM; Teng SC; Wu KJ
    Oncogene; 2007 Mar; 26(10):1459-67. PubMed ID: 16936774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutant Nbs1 enhances cisplatin-induced DNA damage and cytotoxicity in head and neck cancer.
    Tran HM; Shi G; Li G; Carney JP; O'Malley B; Li D
    Otolaryngol Head Neck Surg; 2004 Oct; 131(4):477-84. PubMed ID: 15467621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tid1 functions as a tumour suppressor in head and neck squamous cell carcinoma.
    Chen CY; Chiou SH; Huang CY; Jan CI; Lin SC; Hu WY; Chou SH; Liu CJ; Lo JF
    J Pathol; 2009 Nov; 219(3):347-55. PubMed ID: 19681071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma.
    Masuda M; Suzui M; Yasumatu R; Nakashima T; Kuratomi Y; Azuma K; Tomita K; Komiyama S; Weinstein IB
    Cancer Res; 2002 Jun; 62(12):3351-5. PubMed ID: 12067972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of survival-related genes of the phosphatidylinositol 3'-kinase signaling pathway in glioblastoma multiforme.
    Ruano Y; Mollejo M; Camacho FI; Rodríguez de Lope A; Fiaño C; Ribalta T; Martínez P; Hernández-Moneo JL; Meléndez B
    Cancer; 2008 Apr; 112(7):1575-84. PubMed ID: 18260157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasminogen activator inhibitor-2: a molecular biomarker for head and neck cancer progression.
    Hasina R; Hulett K; Bicciato S; Di Bello C; Petruzzelli GJ; Lingen MW
    Cancer Res; 2003 Feb; 63(3):555-9. PubMed ID: 12566295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of NBS1 contributes to transformation through the activation of phosphatidylinositol 3-kinase/Akt.
    Chen YC; Su YN; Chou PC; Chiang WC; Chang MC; Wang LS; Teng SC; Wu KJ
    J Biol Chem; 2005 Sep; 280(37):32505-11. PubMed ID: 16036916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial cell nicotinic acetylcholine receptor expression in head and neck squamous cell carcinoma pathogenesis.
    Carracedo DG; Rodrigo JP; Nieto CS; Gonzalez MV
    Anticancer Res; 2007; 27(2):835-9. PubMed ID: 17465209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
    Sniezek JC; Matheny KE; Westfall MD; Pietenpol JA
    Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron increases MMP-9 expression through activation of AP-1 via ERK/Akt pathway in human head and neck squamous carcinoma cells.
    Kaomongkolgit R; Cheepsunthorn P; Pavasant P; Sanchavanakit N
    Oral Oncol; 2008 Jun; 44(6):587-94. PubMed ID: 17936676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclin A as a predictive factor for chemotherapy response in advanced head and neck cancer.
    Rodriguez-Pinilla M; Rodriguez-Peralto JL; Hitt R; Sanchez JJ; Ballestin C; Diez A; Sanchez-Verde L; Alameda F; Sanchez-Cespedes M
    Clin Cancer Res; 2004 Dec; 10(24):8486-92. PubMed ID: 15623629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of cell cycle regulatory proteins correlates with advanced tumor stage in head and neck squamous cell carcinomas.
    Nguyen DC; Parsa B; Close A; Magnusson B; Crowe DL; Sinha UK
    Int J Oncol; 2003 Jun; 22(6):1285-90. PubMed ID: 12738995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E-cadherin increases squamous cell carcinoma antigen expression through phosphatidylinositol-3 kinase-Akt pathway in squamous cell carcinoma cell lines.
    Nakagawa T; Murakami A; Torii M; Nawata S; Takeda O; Sugino N
    Oncol Rep; 2007 Jul; 18(1):175-9. PubMed ID: 17549365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression and nuclear translocation of hypoxia-inducible factor prolyl hydroxylase PHD2 in head and neck squamous cell carcinoma is associated with tumor aggressiveness.
    Jokilehto T; Rantanen K; Luukkaa M; Heikkinen P; Grenman R; Minn H; Kronqvist P; Jaakkola PM
    Clin Cancer Res; 2006 Feb; 12(4):1080-7. PubMed ID: 16489060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of RAD17 in head and neck cancer.
    Zhao M; Begum S; Ha PK; Westra W; Califano J
    Head Neck; 2008 Jan; 30(1):35-42. PubMed ID: 17657792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.